Optiprime Oph Gel 3.5 mg Gel is a Health Canada–registered veterinary drug (DIN 00329932) held by Syntex Animal Health, Division Of Syntex Inc., containing Neomycin (Neomycin Sulfate). Health Canada lists its status as Cancelled Post Market (status date 22 Aug 2000).
Health Canada registration
| DIN | 00329932 |
|---|---|
| Brand name | Optiprime Oph Gel |
| Active ingredient | Neomycin (Neomycin Sulfate) |
| Strength | 3.5 mg |
| Dosage form | Gel |
| Route | Ophthalmic |
| Company | Syntex Animal Health, Division Of Syntex Inc. |
| Status | Cancelled Post Market — 22 Aug 2000 |
| Class | Veterinary |
| ATC | |
| AHFS | 08:12.16.08 |
| Regulator record | Health Canada DPD entry · Product monograph |
Regulator price references for Neomycin (Neomycin Sulfate)
Published list or reimbursement prices for Neomycin (Neomycin Sulfate) presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Canada | Optimyxin Plus | 1.75mg | 10,000U/2.5MG/0.025MG PER ML EYE/EAR SOLUTION SOLUTION per unit | 0.73 CAD | reimbursement | Provincial formulary SK | 2026-09-24 |
| Canada | Viaderm KC | 2.5mg | 2.5mg/0.25mg/1mg/gr Ointment Ointment per unit | 0.74 CAD | reimbursement | Provincial formulary NL | 2026-09-24 |
| Canada | Cortisporin | 3.5mg | 1.41 CAD | reimbursement | Provincial formulary BC | 2026-09-24 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Optiprime Oph Gel (DIN 00329932) marketed in Canada?
No. Health Canada lists DIN 00329932 as Cancelled Post Market as of 22 Aug 2000.
Who holds the Canadian licence for this product?
Syntex Animal Health, Division Of Syntex Inc. is the company of record in the Health Canada Drug Product Database.
Is the same medicine registered outside Canada?
No same-molecule registration has been matched in the 56 national registries Nexara Health tracks. Contact us to check manually.
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 00329932, status date 2000-08-22; price sources: Provincial formulary BC, Provincial formulary NL, Provincial formulary SK. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 00329932, status date 2000-08-22; price sources: Provincial formulary BC, Provincial formulary NL, Provincial formulary SK.
Health Canada Drug Product Database (DPD), DIN 00329932, status date 2000-08-22; price sources: Provincial formulary BC, Provincial formulary NL, Provincial formulary SK. Last reviewed 2026-09-29. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.